Willy-Anne Nieuwlaat
Overview
Explore the profile of Willy-Anne Nieuwlaat including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
191
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Butterbrod E, Gehring K, Voormolen E, Depauw P, Nieuwlaat W, Rutten G, et al.
J Neurosurg
. 2019 Aug;
133(3):709-716.
PMID: 31443073
Objective: Patients with nonfunctioning pituitary adenomas (NFPAs) can suffer from cognitive dysfunction. However, the literature on longitudinal cognitive follow-up of patients undergoing endoscopic endonasal transsphenoidal surgery (EETS) is limited. This...
2.
Broekman M, Goedee S, Nieuwlaat W, Depauw P
BMJ Case Rep
. 2013 Sep;
2013.
PMID: 24038289
Hypophysitis is an important differential diagnosis for a pituitary mass, especially in young women at the end of or shortly after pregnancy. It commonly results in hypopituitarism and can be...
3.
Husson O, Nieuwlaat W, Oranje W, Haak H, van de Poll-Franse L, Mols F
Thyroid
. 2013 Apr;
23(10):1247-55.
PMID: 23578315
Background: The aims of this study were (i) to obtain insight into the prevalence of fatigue among short- and long-term thyroid cancer (TC) survivors, by comparing a sample of TC...
4.
Husson O, Haak H, Van Steenbergen L, Nieuwlaat W, van Dijk B, Nieuwenhuijzen G, et al.
Endocr Relat Cancer
. 2013 Mar;
20(2):263-71.
PMID: 23447568
The incidence of thyroid cancer (TC) is increasing worldwide, partly due to increased detection. We therefore assessed combined trends in incidence, survival and mortality of the various types of TC...
5.
Husson O, Haak H, Buffart L, Nieuwlaat W, Oranje W, Mols F, et al.
Acta Oncol
. 2012 Nov;
52(2):249-58.
PMID: 23181387
Background: Given the longevity of thyroid cancer patients, any impairment in health-related quality of life (HRQoL) during the follow-up period is of considerable concern. Therefore, the first aim of this...
6.
Husson O, Haak H, Mols F, Nieuwenhuijzen G, Nieuwlaat W, Reemst P, et al.
Acta Oncol
. 2012 Sep;
52(2):447-54.
PMID: 23013266
Background: To date, no valid instrument is available that focuses on specific health-related quality of life (HRQoL) issues that affect thyroid cancer survivors. The objective of this study was to...
7.
8.
Nieuwlaat W, Hermus A, Ross H, Buijs W, Edelbroek M, Bus J, et al.
J Nucl Med
. 2004 Apr;
45(4):626-33.
PMID: 15073259
Unlabelled: A single, low dose of recombinant human thyroid-stimulating hormone (rhTSH) doubles 24-h RAIU and causes a more homogeneous distribution of radioiodine on thyroid scintigrams of patients with nodular goiter....
9.
Huysmans D, Nieuwlaat W, Hermus A
Clin Endocrinol (Oxf)
. 2004 Mar;
60(3):297-9.
PMID: 15008993
No abstract available.
10.
Nieuwlaat W, Huysmans D, van den Bosch H, Sweep C, Ross H, Corstens F, et al.
J Clin Endocrinol Metab
. 2003 Jul;
88(7):3121-9.
PMID: 12843153
In patients with nodular goiter, radioiodine ((131)I) therapy results in a mean reduction in thyroid volume (TV) of approximately 40% after 1 yr. We have demonstrated that pretreatment with a...